FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a keyDashboard

Company profile

ARS Pharmaceuticals, Inc. Insider Trading

SPRY

Every SEC Form 4 insider trading filing for ARS Pharmaceuticals, Inc. (SPRY) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001671858
Filings
164
Insiders
32
Last filing
2026-09-01
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Margaret Ekins Smith.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. ARS Pharmaceuticals, Inc. insiders are net sellers across the period shown.

PurchasesSales
Q4 23Q1 24Q2 24$41.4MQ3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $41.4M.

90 day insight

Over the last 90 days, ARS Pharmaceuticals, Inc. insiders bought $0 across 2 transactions with no open-market sales.

  • Most active insider: Margaret Ekins Smith with 1 transaction totaling $0.

Activity skews bullish: buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValueReturn
Sep 1, 2026Margaret Ekins SmithSPRY
Award
1,001,738——-13.1% 1w
Jul 1, 2026Donn CasaleSPRY
Award
898,456——-38.7% 1m
Jun 24, 2026Pratik ShahSPRY
Award
30,000——-33.6% 1m
Jun 24, 2026Michael KellySPRY
Award
30,000——-33.6% 1m
Jun 24, 2026Saqib IslamSPRY
Award
30,000——-33.6% 1m

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=SPRY" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

James E Flynn10% owner2 filings−$13.7M
Justin ChakmaChief Business Officer3 filings−$1.5M
Richard E LowenthalPRESIDENT AND CEO1 filing−$724K
Sarina TanimotoCHIEF MEDICAL OFFICER2 filings−$704K
Eric KarasChief Commercial Officer4 filings−$445K

Institutional Ownership

Top 13F-HR holders of ARS Pharmaceuticals, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$151.8M
QoQ change
-79.0%
Reporting period
2026-06-30
#1
Aberdeen Group plc
CIK 0001716774
$33.4M
4.2M shares
#2
State Street Corp
CIK 0000093751
$29.9M
3.7M shares
#3
BlackRock, Inc.
CIK 0002012383
$22.7M
2.8M shares

Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.RCGRENN Fund, Inc.METAMeta Platforms, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/